Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Breast (Edinburgh, Scotland)|December 19, 2025
Comparative validation of PREDICT versions 3.1 and 2.2 for overall survival in the Dutch breast cancer populationLara W A Vreven, Elfi M Verheul, Marissa C van Maaren, et al.
European Journal of Clinical Investigation|March 12, 2002
Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturationP H Gosselaar, A J G van-Dijk, G C de-Gast, et al.
Clinical Chemistry and Laboratory Medicine|January 15, 2013
A multiplex assay to rapidly exclude HLA-DQ2.5 and HLA-DQ8 expression in patients at risk for celiac diseaseEllen M van Beek, Elianne A Roelandse-Koop, Raymon Vijzelaar, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2019
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trialCharlotte M Huijts, Sinéad M Lougheed, Zuhir Bodalal, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|September 18, 2009
A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genesD A M Heideman, F B Thunnissen, M Doeleman, et al.
Molecular Cancer Therapeutics|May 27, 2010
Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft studyHans J Hammers, Henk M Verheul, Brenda Salumbides, et al.
Blood|August 12, 2011
Blood platelets contain tumor-derived RNA biomarkersR Jonas A Nilsson, Leonora Balaj, Esther Hulleman, et al.
Cancer Research|May 13, 2010
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activityElisa Giovannetti, Niccola Funel, Godefridus J Peters, et al.
Cancer Immunology, Immunotherapy : CII|November 11, 2018
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinomaCharlotte M Huijts, Inge M Werter, Sinéad M Lougheed, et al.
Human Reproduction (Oxford, England)|December 14, 2007
Difference in signalling between various hormone therapies in endometrium, myometrium and upper part of the vaginaPayman Hanifi-Moghaddam, Bianca Boers-Sijmons, Anet H A Klaassens, et al.
Pageof 12